Rallybio Corp
RLYB
Get informed when a big investor buys or sells
+ FollowMarket Cap$90.16M
Close$
$6.82
59.8% downside
Current Fair Value
59.8% downsideOvervalued by 59.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $90.16 Million |
|---|---|
| Enterprise Value | $-1,415,871.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.59 |
| Beta | -0.86 |
| Outstanding Shares | 5,699,111 |
Return
| Return on Equity | 48.20% |
|---|---|
| Return on Assets | 46.45% |
| Return on Invested Capital | 28.49% |
Valuation & Multiples
| P/E Ratio | 2.14 |
|---|---|
| PEG | -0.39 |
| Price to Sales | - |
| Price to Book Ratio | 1.06 |
| Enterprise Value to Revenue | -2.19 |
| Enterprise Value to EBIT | -0.05 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | -0.9 |
| Debt to Equity | 0.01 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 6, 2026
EPS Estimate
$-1.28
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-1.44
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 82.03%▲ 26.69% |
|---|---|
| Total Invested | $41.85M▲ 101.87% |
| Investors Holding | 38▼ 7.00% |
ESG Score
No data
About Rallybio Corp
2,021 employees